Windtree slides on CEO retirement

Windtree Therapeutics

14/11/2024 20:54

** Shares of biotechnology firm Windtree Therapeutics
 WINT.O  down 8.30% at about $0.49 
    ** CEO Craig Fraser to retire, effective Dec. 1
    ** Fraser to remain on the board as chairman
    ** Jed Latkin, current director, appointed as CEO
    ** Including session gains, stock had fallen 96.1% YTD




 (Reporting by Nithyashree  R B)
 ((NithyashreeRB@thomsonreuters.com;))